Answers are grounded in this paper and cite their sources.
Preliminary results for influenza vaccine effectiveness (VE) against acute respiratory illness with circulating laboratory-confirmed influenza viruses in New Zealand from 27 April to 26 September 2015, using a case test-negative design were 36% (95% confidence interval (CI): 11-54) for general practice encounters and 50% (95% CI: 20-68) for hospitalisations. VE against hospitalised influenza A(H3N2) illnesses was moderate at 53% (95% CI: 6-76) but improved compared with previous seasons.
No takes yet. Share an insight, caveat, or question.
Bissielo et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: